Mpm Asset Management as of March 31, 2014
Portfolio Holdings for Mpm Asset Management
Mpm Asset Management holds 12 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Epizyme | 23.3 | $55M | 2.4M | 22.77 | |
| Aratana Therapeutics | 21.9 | $52M | 2.8M | 18.56 | |
| Macrogenics (MGNX) | 21.0 | $50M | 1.8M | 27.83 | |
| Portola Pharmaceuticals | 13.4 | $32M | 1.2M | 25.90 | |
| Celladon | 5.4 | $13M | 1.1M | 11.92 | |
| PharmAthene | 4.9 | $12M | 6.3M | 1.83 | |
| Conatus Pharmaceuticals | 4.1 | $9.7M | 1.2M | 8.14 | |
| Verastem | 3.7 | $8.8M | 817k | 10.79 | |
| Pacira Pharmaceuticals (PCRX) | 1.2 | $2.7M | 39k | 69.98 | |
| EnteroMedics | 0.9 | $2.0M | 1.1M | 1.82 | |
| Sangamo Biosciences (SGMO) | 0.2 | $407k | 23k | 18.10 | |
| Mast Therapeutics | 0.1 | $362k | 525k | 0.69 |
